MEI Pharma, Inc.
-
Ticker
MEIP
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in San Diego, California
MEI Pharma, Inc. (NASDAQ: MEIP) is a late-stage pharmaceutical company focused on developing potential new therapies for cancer. MEI Pharma's portfolio of drug candidates contains four clinical-stage assets, including zandelisib, currently in an ongoing Phase 2 clinical trial which may support an accelerated approval marketing application with the U.S. Food and Drug Administration. Each
…More of MEI Pharma's pipeline candidates leverages a different mechanism of action with the objective of developing therapeutic options that are: (1) differentiated, (2) address unmet medical needs and (3) deliver improved benefit to patients either as standalone treatments or in combination with other therapeutic options.
REPORT RATINGS
5.0 / 5.0 (1)
MEI Pharma, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.
MEI Pharma, Inc.
Most Recent Responsibility Report
MOST RECENT
2022 ESG Report
Our service enables potential investors to review the most recent and archived MEI Pharma, Inc. Sustainability Report, MEI Pharma, Inc. Corporate Social Responsibility Report, MEI Pharma, Inc. CSR Report, MEI Pharma, Inc. Corporate Responsibility, MEI Pharma, Inc. CR Report, MEI Pharma, Inc. Citizenship Report, MEI Pharma, Inc. ESG Report, and MEI Pharma, Inc. Environmental Report online.